NOVN.SW vs. IWDA.AS

Last updated Jun 5, 2026

NOVN.SW (Novartis AG) is a stock, while IWDA.AS (iShares Core MSCI World UCITS ETF USD (Acc)) is Global Equities fund tracking the MSCI World Index. Over the past 10 years, NOVN.SW returned 9.98%/yr vs 10.76%/yr for IWDA.AS. At a 0.46 correlation, their price movements are largely independent.

Performance

NOVN.SW vs. IWDA.AS - Performance Comparison

The chart below illustrates the hypothetical performance of a CHF 10,000 investment in Novartis AG (NOVN.SW) and iShares Core MSCI World UCITS ETF USD (Acc) (IWDA.AS). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

NOVN.SW is traded in CHF, while IWDA.AS is traded in EUR. To make them comparable, the IWDA.AS values have been converted to CHF using the latest available exchange rates.

Returns By Period

The year-to-date returns for both investments are quite close, with NOVN.SW having a 8.91% return and IWDA.AS slightly higher at 9.29%. Over the past 10 years, NOVN.SW has underperformed IWDA.AS with an annualized return of 9.98%, while IWDA.AS has yielded a comparatively higher 10.76% annualized return.

NOVN.SW

• 1D: 2.04%
• 1M: 2.19%
• YTD: 8.91%
• 6M: 11.93%
• 1Y: 22.96%
• 3Y*: 14.41%
• 5Y*: 12.76%
• 10Y*: 9.98%

IWDA.AS

• 1D: -0.24%
• 1M: 3.95%
• YTD: 9.29%
• 6M: 8.48%
• 1Y: 20.68%
• 3Y*: 15.31%
• 5Y*: 8.97%
• 10Y*: 10.76%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NOVN.SW vs. IWDA.AS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NOVN.SW Novartis AG	8.91%	27.98%	8.44%	11.93%	8.75%	-0.11%	-5.39%	28.50%	6.51%	16.04%
IWDA.AS iShares Core MSCI World UCITS ETF USD (Acc)	9.29%	6.13%	28.77%	12.61%	-17.62%	27.15%	5.86%	24.91%	-7.74%	17.49%

Correlation

The correlation between NOVN.SW and IWDA.AS is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.11
Correlation (3Y) Calculated over the trailing 3-year period	0.17
Correlation (5Y) Calculated over the trailing 5-year period	0.23
Correlation (10Y) Calculated over the trailing 10-year period	0.39
Correlation (All Time) Calculated using the full available price history since Oct 20, 2009	0.46

Over the past year, the correlation between NOVN.SW and IWDA.AS has dropped to 0.11 - well below their long-term average of 0.46, suggesting their price drivers have been diverging.

Return for Risk

NOVN.SW vs. IWDA.AS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NOVN.SW

NOVN.SW Risk / Return Rank: 75
NOVN.SW Sharpe Ratio Rank: 79
NOVN.SW Sortino Ratio Rank: 72
NOVN.SW Omega Ratio Rank: 72
NOVN.SW Calmar Ratio Rank: 77
NOVN.SW Martin Ratio Rank: 77

IWDA.AS

IWDA.AS Risk / Return Rank: 71
IWDA.AS Sharpe Ratio Rank: 66
IWDA.AS Sortino Ratio Rank: 67
IWDA.AS Omega Ratio Rank: 69
IWDA.AS Calmar Ratio Rank: 74
IWDA.AS Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NOVN.SW vs. IWDA.AS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NOVN.SW) and iShares Core MSCI World UCITS ETF USD (Acc) (IWDA.AS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NOVN.SW	IWDA.AS	Difference
Sharpe ratio: Return per unit of total volatility	1.34	1.85	-0.52
Sortino ratio: Return per unit of downside risk	1.80	2.55	-0.75
Omega ratio: Gain probability vs. loss probability	1.24	1.33	-0.09
Calmar ratio: Return relative to maximum drawdown	2.29	2.73	-0.43
Martin ratio: Return relative to average drawdown	5.53	8.82	-3.29
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NOVN.SW vs. IWDA.AS - Sharpe Ratio Comparison

The current NOVN.SW Sharpe Ratio is 1.34, which is comparable to the IWDA.AS Sharpe Ratio of 1.85. The chart below compares the historical Sharpe Ratios of NOVN.SW and IWDA.AS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NOVN.SW	IWDA.AS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.34	1.85	-0.52
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.72	0.58	+0.13
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.55	0.66	-0.11
Sharpe Ratio (All Time) Calculated using the full available price history	0.48	0.53	-0.05

Drawdowns

NOVN.SW vs. IWDA.AS - Drawdown Comparison

The maximum NOVN.SW drawdown since its inception was -42.25%, which is greater than IWDA.AS's maximum drawdown of -36.92%. Use the drawdown chart below to compare losses from any high point for NOVN.SW and IWDA.AS.

Drawdown Indicators

	NOVN.SW	IWDA.AS	Difference
Max Drawdown Largest peak-to-trough decline	-42.25%	-36.92%	-5.33%
Max Drawdown (1Y) Largest decline over 1 year	-10.78%	-7.78%	-3.00%
Max Drawdown (3Y) Largest decline over 3 years	-16.86%	-22.04%	+5.18%
Max Drawdown (5Y) Largest decline over 5 years	-16.86%	-22.04%	+5.18%
Max Drawdown (10Y) Largest decline over 10 years	-24.11%	-34.06%	+9.95%
Current Drawdown Current decline from peak	-8.53%	-0.24%	-8.29%
Average Drawdown Average peak-to-trough decline	-11.40%	-5.59%	-5.81%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.43%	2.42%	+2.01%

Volatility

NOVN.SW vs. IWDA.AS - Volatility Comparison

Novartis AG (NOVN.SW) has a higher volatility of 6.01% compared to iShares Core MSCI World UCITS ETF USD (Acc) (IWDA.AS) at 2.53%. This indicates that NOVN.SW's price experiences larger fluctuations and is considered to be riskier than IWDA.AS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NOVN.SW	IWDA.AS	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.01%	2.53%	+3.48%
Volatility (6M) Calculated over the trailing 6-month period	13.12%	7.89%	+5.23%
Volatility (1Y) Calculated over the trailing 1-year period	18.53%	11.46%	+7.07%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.81%	15.10%	+2.71%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.23%	15.95%	+2.28%

Dividends

NOVN.SW vs. IWDA.AS - Dividend Comparison

NOVN.SW's dividend yield for the trailing twelve months is around 3.19%, while IWDA.AS has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
IWDA.AS iShares Core MSCI World UCITS ETF USD (Acc)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOVN.SW Novartis AG	3.19%	3.19%	3.72%	3.77%	3.91%	3.94%	3.72%	3.27%	3.98%	3.98%	4.35%	3.58%

Frequently Asked Questions

Can I hold both NOVN.SW and IWDA.AS in my portfolio?

NOVN.SW and IWDA.AS have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.